Options for myeloma patients who have undergone Darzalex (daratumumab) therapy and relapsed


In this week’s video, Dr. Brian G.M. Durie explains that if you relapse on Darzalex, it is important to carefully discuss all treatment options with your doctor.

If you relapse while on Darzalex, consider all options including upping dosing, new combination therapies, second transplant, or even a clinical trial.

Have a question? Submit it to AskDrDurie@myeloma.org

IMF Chairman and Co-Founder Brian G.M. Durie, MD welcomes your questions about the latest myeloma treatments, research, controversies and quality of life issues. If you have a question you think might be of interest to the myeloma community, please send to askdrdurie@myeloma.org!

For questions of a specific personal nature, please call the IMF InfoLine coordinators at 800.452.2873 or email them at infoline@myeloma.org